A skin patch delivering peptides derived from the presumed autoimmune target in multiple sclerosis reduced relapse frequency and brain lesions in a pilot clinical trial, researchers said.
In 30 patients with relapsing-remitting MS enrolled in the 1-year, placebo-controlled trial, those receiving the myelin skin patches containing 1 mg of peptides had an annualized relapse rate of 0.43 versus 1.4 in patients treated with a placebo patch (P=0.007), according to Krzysztof Selmaj, MD, PhD, of the Medical University of Lodz in Poland, and colleagues...........Read More - http://www.ms-uk.org/index.cfm/myelin
Multiple Sclerosis myelin skin patch trial shows promise
Multiple Sclerosis myelin skin patch trial shows promise
MS-UK - http://www.ms-uk.org/
-
- Similar Topics
- Replies
- Views
- Last post
-
- 3 Replies
- 1058 Views
-
Last post by Scott1
-
- 0 Replies
- 1460 Views
-
Last post by frodo
-
- 0 Replies
- 1527 Views
-
Last post by frodo
-
- 1 Replies
- 1736 Views
-
Last post by frodo
-
- 0 Replies
- 1672 Views
-
Last post by frodo
-
- 0 Replies
- 2067 Views
-
Last post by frodo
-
- 0 Replies
- 1765 Views
-
Last post by NHE
-
- 0 Replies
- 1139 Views
-
Last post by frodo
-
- 0 Replies
- 3506 Views
-
Last post by frodo